Division of Gynecology, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Am J Obstet Gynecol. 2010 Mar;202(3):278.e1-6. doi: 10.1016/j.ajog.2009.10.882. Epub 2009 Dec 22.
The purpose of this study was to determine posthysterectomy pathologic findings in patients with a preoperative endometrial sampling diagnosis of International Federation of Gynecology and Obstetrics (FIGO) grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia (CAH).
We reviewed 1423 consecutive cases of endometrial cancer to identify cases with a preoperative endometrial biopsy that demonstrated FIGO grade 1 endometrial adenocarcinoma. Final uterine pathologic findings were grouped into low- and high-risk based on FIGO and Gynecologic Oncology Group criteria.
We identified 123 cases with a background of CAH and 367 cases without a background of CAH. FIGO grade in the hysterectomy specimen was more than FIGO grade 1 in 11 of 123 cases (8.9%) with a background of CAH, compared with 60 of 359 cases (16.7%) without a background of CAH (P = .04).
An endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of CAH is more likely to correlate with final posthysterectomy grade than a diagnosis not arising with a background of CAH.
本研究旨在确定术前子宫内膜取样诊断为国际妇产科联合会(FIGO)分级 1 子宫内膜腺癌伴复杂不典型增生(CAH)背景的患者在子宫切除术后的病理发现。
我们回顾了 1423 例连续的子宫内膜癌病例,以确定术前子宫内膜活检显示 FIGO 分级 1 子宫内膜腺癌的病例。最终的子宫病理结果根据 FIGO 和妇科肿瘤学组标准分为低危和高危组。
我们在 123 例伴有 CAH 背景的病例和 367 例无 CAH 背景的病例中发现,在伴有 CAH 背景的 123 例病例中,有 11 例(8.9%)的子宫切除标本FIGO 分级高于 FIGO 分级 1 级,而在无 CAH 背景的 359 例病例中,有 60 例(16.7%)的子宫切除标本FIGO 分级高于 FIGO 分级 1 级(P=0.04)。
伴有 CAH 背景的术前子宫内膜取样诊断为 FIGO 分级 1 子宫内膜腺癌与最终子宫切除术后分级的相关性高于无 CAH 背景的诊断。